Eosinophilic esophagitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) |
|||
| Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
The | *The medical therapy of the EoE is as follows:<ref>{{Cite journal| doi = 10.1038/ajg.2013.71| issn = 1572-0241| volume = 108| issue = 5| pages = 679–692; quiz 693| last1 = Dellon| first1 = Evan S.| last2 = Gonsalves| first2 = Nirmala| last3 = Hirano| first3 = Ikuo| last4 = Furuta| first4 = Glenn T.| last5 = Liacouras| first5 = Chris A.| last6 = Katzka| first6 = David A.| last7 = American College of Gastroenterology| title = ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)| journal = The American Journal of Gastroenterology| date = 2013-05| pmid = 23567357}}</ref> | ||
*The optimal treatment of [[eosinophilic esophagitis]] remains uncertain. | |||
*The endpoints of therapy of [[eosinophilic esophagitis]] include improvements in clinical symptoms and esophageal [[eosinophilic]] [[inflammation]]. *An eight-week course of therapy with topical corticosteroids ('''[[fluticasone]]''' | |||
*Children | |||
**88–440 mcg/day [[fluticasone]] | |||
**1 mg/day [[budesonide]] | |||
*Adults | |||
**880–1760 mcg/day [[fluticasone]] | |||
**2 mg/day [[budesonide]] may be used as the first-line pharmacologic therapy. | |||
*Patients without symptomatic and histologic improvement after topical [[steroids]] | |||
**Long course or higher doses of topical [[steroids]] | |||
**Systemic [[steroids]] with [[prednisone]] | |||
**Dietary elimination | |||
**Endoscopic dilation | |||
*Evaluation by an allergist for coexisting [[atopy|atopic disorders]] and food and environmental [[allergens]] is advisable. | |||
*[[Allergen]] elimination usually leads to improvement in [[dysphagia]] and reduction of [[eosinophil]] infiltration. | |||
*Graduated dilation of [[esophageal stricture]] should be performed with caution to minimize the risk of iatrogenic [[perforation]]. | |||
==References== | ==References== | ||
Revision as of 02:32, 7 December 2017
|
Eosinophilic Esophagitis Microchapters |
|
Differentiating Eosinophilic Esophagitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Eosinophilic esophagitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Eosinophilic esophagitis medical therapy |
|
Risk calculators and risk factors for Eosinophilic esophagitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The optimal treatment of eosinophilic esophagitis remains uncertain. An eight-week course of therapy with topical corticosteroids (fluticasone or budesonide) may be used as the first-line pharmacologic therapy. Allergen elimination usually leads to improvement in dysphagia and reduction of eosinophil infiltration. Esophageal dilation of is generally reserved for refractory cases with esophageal stricture.
Medical Therapy
- The medical therapy of the EoE is as follows:[1]
- The optimal treatment of eosinophilic esophagitis remains uncertain.
- The endpoints of therapy of eosinophilic esophagitis include improvements in clinical symptoms and esophageal eosinophilic inflammation. *An eight-week course of therapy with topical corticosteroids (fluticasone
- Children
- 88–440 mcg/day fluticasone
- 1 mg/day budesonide
- Adults
- 880–1760 mcg/day fluticasone
- 2 mg/day budesonide may be used as the first-line pharmacologic therapy.
- Patients without symptomatic and histologic improvement after topical steroids
- Long course or higher doses of topical steroids
- Systemic steroids with prednisone
- Dietary elimination
- Endoscopic dilation
- Evaluation by an allergist for coexisting atopic disorders and food and environmental allergens is advisable.
- Allergen elimination usually leads to improvement in dysphagia and reduction of eosinophil infiltration.
- Graduated dilation of esophageal stricture should be performed with caution to minimize the risk of iatrogenic perforation.
References
- ↑ Dellon, Evan S.; Gonsalves, Nirmala; Hirano, Ikuo; Furuta, Glenn T.; Liacouras, Chris A.; Katzka, David A.; American College of Gastroenterology (2013-05). "ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)". The American Journal of Gastroenterology. 108 (5): 679–692, quiz 693. doi:10.1038/ajg.2013.71. ISSN 1572-0241. PMID 23567357. Check date values in:
|date=(help)